Advice You - Business

The other day I received an e-mail from an internet marketer who was bemoaning the fact that calling people on the no-call list

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

is now illegal and that puts such limits on marketing. He is far and away not the only one with that viewpoint; I find it almos

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

everywhere I look. In fact, it is almost universal among marketers. You know what? I frankly don’t understand why they feel

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

that way.

If there is one marketing perspective that is more universal than hatred for the no-call list, it is that in order to

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

be successful in the world of marketing, you have to focus. Focus on your customer. Focus on your target audience. Focus on y

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ur target niche. Focus, focus, focus. So why would you want to waste your time and energy and money and every other imaginable

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

resource spraying your message out to people that are guaranteed NOT to want your product or service, no matter how wonderful y

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

u just KNOW it is?

Marketers spend a lot of money buying leads, hoping that if they send just the right message about just the

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

right product or service to just the right people who have already agreed to hear the message, enough of them will buy the produ

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

t or service to make the marketer a decent living. If the marketer is good enough at his or her craft, he or she will indeed ma

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

e a good living. Most of them will tell you that it’s a numbers game. With enough “good” leads, or enough “targeted” leads, us

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ually numbering many thousand, there will be enough interested customers to support the marketer.

What I don’t understand is wh

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

marketers don’t think of the no-call list as “reverse leads.” These are people who have made it loud and clear that they are n

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ot interested. I mean, how targeted can you get? Here marketers have been handed, on a silver platter, totally free, a whole l

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

st of people NOT to waste time on! I just can’t see why marketers can’t see the value in this! The no-call list has done a ver

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

effective job of weeding out a large portion of people who have indicated they are NOT INTERESTED in whatever it is you are sel

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ling! Marketers should be thanking them for helping to create more targeted lists!

So how about it, marketers? Can you see th

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

s glass as half full instead of half empty? Can you express gratitude for what you have been given instead of grumbling and com

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

plaining about what has been taken away? Can you now see those of us on the no-call list as “chaff” that has been removed from

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

he ripe kernels of grain to whom you can now more effectively market? If not, maybe you need to adjust your “stinkin’ thinkin’”

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/29963/adviceyou-A-Different-Perspective-On-The-NoCall-List.html">A Different Perspective On The No-Call List</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/29963/adviceyou-A-Different-Perspective-On-The-NoCall-List.html]A Different Perspective On The No-Call List[/url]

Having had a busy week, I was only too happy to don my gardening clothes and get outside to do some planting, weeding and pruning last weekend. “It’s interesting”, I thought, “how business refers to a slight improvement as the green shoots of recovery”. I then began to think of other gardening analogies that could be applied to business.

Proponents of e-learning often cite as an advantage the fact that people can take the training at their desks, on their own schedule. The problem is everyone is so busy that it's difficult to find the time. There are other disadvantages to learning at your desk.

The marketing paradigm that can literally make or break your coaching business. What's the single most important process determining whether or not your coaching business is successful?

Tags

Links

Advice You - A Different Perspective On The No-Call List

Related Articles: